Spots Global Cancer Trial Database for clear cell sarcoma

Every month we try and update this database with for clear cell sarcoma cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study title	NCT ID	Conditions	Interventions	Eligibility	Organization
Simvastatin With Topotecan and Cyclophosphamide in Relapsed and/or Refractory Pediatric Solid and CNS Tumors	NCT02390843	Retinoblastoma Clear Cell Sarc... Renal Cell Carc... Rhabdoid Tumor Wilms Tumor Hepatoblastoma Neuroblastoma Germ Cell Tumor... Ewings Sarcoma Non-rhabdomyosa... Osteosarcoma Rhabdomyosarcom...	Simvastatin Cyclophosphamid... Topotecan Myeloid growth ...	1 Year - 29 Years	Emory University
Clinical Trial of SP-2577 (Seclidemstat) in Patients With Relapsed or Refractory Ewing or Ewing-related Sarcomas	NCT03600649	Ewing Sarcoma Myxoid Liposarc... Sarcoma,Soft Ti... Desmoplastic Sm... Extraskeletal M... Angiomatoid Fib... Clear Cell Sarc... Primary Pulmona... Myoepithelial T... Sclerosing Epit... Fibromyxoid Tum...	Seclidemstat Cyclophosphamid... Topotecan	12 Years -	Salarius Pharmaceuticals, LLC
Molecular-Guided Therapy for Childhood Cancer	NCT02162732	Neuroblastoma Medulloblastoma Glioma Ependymoma Choroid Plexus ... Craniopharyngio... Dysembryoplasti... Meningioma Primitive Neuro... Germ Cell Tumor... Rhabdomyosarcom... Non-rhabdomyosa... Ewings Sarcoma Osteosarcoma Wilms Tumor Renal Cell Carc... Malignant Rhabd... Clear Cell Sarc... Liver Tumors	Guided Therapy	13 Months - 21 Years	Milton S. Hershey Medical Center
A Rollover Protocol to Allow for Continued Access to the LSD1 Inhibitor Seclidemstat (SP-2577)	NCT05266196	Ewing Sarcoma Myxoid Liposarc... Desmoplastic Sm... Extraskeletal M... Angiomatoid Fib... Clear Cell Sarc... Myoepithelial T... Low Grade Fibro... Sclerosing Epit...	Seclidemstat	12 Years -	Salarius Pharmaceuticals, LLC
B7H3 CAR T Cell Immunotherapy for Recurrent/Refractory Solid Tumors in Children and Young Adults	NCT04483778	Pediatric Solid... Germ Cell Tumor Retinoblastoma Hepatoblastoma Wilms Tumor Rhabdoid Tumor Carcinoma Osteosarcoma Ewing Sarcoma Rhabdomyosarcom... Synovial Sarcom... Clear Cell Sarc... Malignant Perip... Desmoplastic Sm... Soft Tissue Sar... Neuroblastoma Melanoma	second generati... second generati... Pembrolizumab	0 Years - 26 Years	Seattle Children's Hospital
Clinical Trial of SP-2577 (Seclidemstat) in Patients With Relapsed or Refractory Ewing or Ewing-related Sarcomas	NCT03600649	Ewing Sarcoma Myxoid Liposarc... Sarcoma,Soft Ti... Desmoplastic Sm... Extraskeletal M... Angiomatoid Fib... Clear Cell Sarc... Primary Pulmona... Myoepithelial T... Sclerosing Epit... Fibromyxoid Tum...	Seclidemstat Cyclophosphamid... Topotecan	12 Years -	Salarius Pharmaceuticals, LLC
Simvastatin With Topotecan and Cyclophosphamide in Relapsed and/or Refractory Pediatric Solid and CNS Tumors	NCT02390843	Retinoblastoma Clear Cell Sarc... Renal Cell Carc... Rhabdoid Tumor Wilms Tumor Hepatoblastoma Neuroblastoma Germ Cell Tumor... Ewings Sarcoma Non-rhabdomyosa... Osteosarcoma Rhabdomyosarcom...	Simvastatin Cyclophosphamid... Topotecan Myeloid growth ...	1 Year - 29 Years	Emory University
B7-H3-Specific Chimeric Antigen Receptor Autologous T-Cell Therapy for Pediatric Patients With Solid Tumors (3CAR)	NCT04897321	Pediatric Solid... Osteosarcoma Rhabdomyosarcom... Neuroblastoma Ewing Sarcoma Wilms Tumor Adrenocortical ... Desmoplastic Sm... Germ Cell Cance... Rhabdoid Tumor Clear Cell Sarc... Hepatoblastoma Melanoma Carcinoma Malignant Perip... Soft Tissue Sar...	Fludarabine Cyclophosphamid... MESNA B7-H3 CAR T cel...	- 21 Years	St. Jude Children's Research Hospital
A Rollover Protocol to Allow for Continued Access to the LSD1 Inhibitor Seclidemstat (SP-2577)	NCT05266196	Ewing Sarcoma Myxoid Liposarc... Desmoplastic Sm... Extraskeletal M... Angiomatoid Fib... Clear Cell Sarc... Myoepithelial T... Low Grade Fibro... Sclerosing Epit...	Seclidemstat	12 Years -	Salarius Pharmaceuticals, LLC
EGFR806 CAR T Cell Immunotherapy for Recurrent/Refractory Solid Tumors in Children and Young Adults	NCT03618381	Pediatric Solid... Germ Cell Tumor Retinoblastoma Hepatoblastoma Wilms Tumor Rhabdoid Tumor Carcinoma Osteosarcoma Ewing Sarcoma Rhabdomyosarcom... Synovial Sarcom... Clear Cell Sarc... Malignant Perip... Desmoplastic Sm... Soft Tissue Sar... Neuroblastoma	second generati... second generati...	1 Year - 30 Years	Seattle Children's Hospital

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

Join others from around the world: